Back to trial details

Intake questionnaire

Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer

Applying to Dartmouth Cancer Center/Dartmouth-Hitchcock Medical Center · Lebanon, New Hampshire

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Relapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast Cancer?
3. Are you able to travel to Lebanon for study visits?